Aravind Eye Hospital
Madurai, Tamil Nadu, 625 020, India
NCT Number: NCT00717080
This is a Randomized Controlled Trial to study the role of Capsular Tension Ring in patients with Retinitis Pigmentosa
Looking for future studies?
Notify Me35 year–65 year
All sexes
Interventional
Phase 4
Madurai, Tamil Nadu, 625 020, India
Cataract is a common complication in retinitis Pigmentosa (RP) patient especially posterior sub capsular cataract. Continuous curvilinear capsulorhexis is the preferred method of capsulotomy in cataract surgery. Anterior capsular contraction (ACO) is a unique complication following cataract surgery. The rate of which is higher in RP patients due to the weak zonules and the increased rate of inflammation. CTR has been proven to reduce the rate of contraction.
Study population includes 40 eyes having RP with cataract. 20 eyes will receive CTR and the other 20 would not receive CTR. The percentage of anterior capsular contraction would be evaluated using EPCO software.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
IOL surgery using capsular tension ring (AURORING)
Other names: AURORING
Time frame: 1 day, 30 days,90 days,180 days,270days
Time frame: 1 day, 30 days,90 days,180 days,270days
Aurolab
Other
Role of Capsular Tension Ring in Anterior Capsular Contraction in Retinitis Pigmentosa Patients
Acronym: ACO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00559234
Cataract, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Bethesda, Maryland, United States
View Trial DetailsNCT03374657
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Stockholm, Sweden
View Trial DetailsNCT05282953
Choroid Diseases, Choroideremia
Sydney, New South Wales, Australia
View Trial DetailsNCT05392179
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Durham, North Carolina, United States
View Trial Details